Cleveland Clinic Brain Study: A First-of-Kind Longitudinal Investigation
Andre Machado, MD, PhD and Imad Najm, MD, discuss a first-of-kind study aimed at identifying biomarkers and targets for preventing and curing neurodegenerative disorders and other neurologic diseases. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.
Subscribe: Apple Podcasts | Google Podcasts | Spotify | Buzzsprout
Cleveland Clinic Brain Study: A First-of-Kind Longitudinal Investigation
Neuro Pathways
A Cleveland Clinic podcast for medical professionals exploring the latest research discoveries and clinical advances in the fields of neurology, neurosurgery, neurorehab and psychiatry. Learn how the landscape for treating conditions of the brain, spine and nervous system is changing from experts in Cleveland Clinic's Neurological Institute.
These activities have been approved for AMA PRA Category 1 Credits™ and ANCC contact hours.
